Get started

Specialitychemical

Aether Industry — 92% profit growth and zero debt NSE:AETHER A silent specialty chemical beast—92% profit growth and zero debt...! 🏢 **Company Overview:** Aether Industries is a Surat-based specialty chemical manufacturer focused on high-margin, research-driven intermediates used in pharmaceuticals, agrochemicals, coatings, and oil & gas. It is known for proprietary process chemistry and niche product innovation. 📈 Fundamental Analysis: ✅ Key Financials (FY25 Estimates): Market Cap: ₹10,900 Cr Revenue: ₹838 Cr (+40% YoY) Net Profit: ₹158 Cr (+92% YoY) EBITDA Margin: ~32% Net Profit Margin: ~19% ROE / ROCE: ~7.4% / ~6% P/E Ratio: ~70x Debt to Equity: ~0.06 (Debt-free) 🧩 Strengths: Fast-growing specialty chemical company with proprietary products. Debt-free and financially stable. High-margin CRAMS and contract manufacturing model. ⚠️ Risks: Valuation is rich, pricing in future growth. Return ratios (ROE/ROCE) are modest compared to peers. 📊 Technical Analysis (As of July 2025): CMP: ₹823 52-Week Range: ₹725 – ₹1,071 Moving Averages: Price above 50/100-day MAs; approaching 200-day MA RSI: ~65 (Neutral–Bullish) MACD: Neutral to Mild Bullish Support: ₹780 – ₹800 Resistance: ₹832 – ₹840 📉 Short-Term Outlook: A breakout above ₹840 may trigger upside to ₹900+. A close below ₹800 could lead to short-term weakness. 🚀 Future Growth Prospects: High-Margin Niche Leadership: Focused on low-volume, high-value intermediates with global demand. Strong Financial Performance: Consistent revenue and profit growth; scalable R&D-driven model. Export & Global Pharma Exposure: Major clients across US, EU, and Japan. New Capacity Expansion: Setting up new manufacturing blocks to double capacity over the next 2 years. 📝 Conclusion: Parameter Verdict Fundamentals 🔵 Strong – R&D-led growth with clean balance sheet Technicals 🟠 Mixed – needs breakout above key resistance Valuation 🟠 Expensive – high P/E, growth priced in Long-Term View ✅ Positive – niche specialty play Short-Term View 🔄 Wait for breakout or accumulate on dips ========================================================== ========================================================== ⚠️ Disclaimer: This analysis is for educational and informational purposes only. We are not SEBI-registered analysts or advisors. This is our personal view based on available data and market trends. Please consult your SEBI-registered investment advisor before making any investment or trading decisions. You are solely responsible for any financial decisions you make based on this content. ======================== Trade Secrets By Pratik ========================
NSE:AETHERLong
by Trade_Secrets_By_Pratik
Rossari: Ready to Break Out from Multi-Month ConsolidationNSE:ROSSARI : Hidden Gem Ready to Break Out from Multi-Month Consolidation - My Technical Analysis & Trade Setup on this beautiful Chart Structure Price Action: - Stock has been in a prolonged consolidation phase since March 2025, after a significant decline from highs near 970 levels - Current price action shows the formation of a symmetrical triangle pattern with converging trend lines - Recent price movement indicates a potential breakout attempt with increased volume participation - The stock has found strong support around 580-600 levels and resistance near the 720-740 zone Volume Spread Analysis: Volume Characteristics: - Volume has been declining during the consolidation phase, which is typical for triangle patterns - Recent sessions show increasing volume participation, suggesting institutional interest - Volume spike during recent upward movement indicates genuine buying interest - Average volume appears to be around 300-400K shares, with recent pickup to 620K+ Volume Confirmation Signals: - Higher volume on up days compared to down days in recent sessions - Volume expansion during the recent breakout attempt - Accumulation pattern visible in volume profile during base formation Base Formation: - Primary base formation: Large consolidation base formed between 580-740 levels over 7+ months - Base characteristics: Symmetrical triangle with higher lows - Base depth: Approximately 27% from resistance to support levels - Time duration: An Extended 7-month base suggests a strong accumulation phase Key Support and Resistance Levels: - Immediate Support: 680-690 (recent swing low) - Major Support: 580-600 (tested multiple times, strong buying interest) - Immediate Resistance: 720-740 (upper trend line of triangle) - Major Resistance: 800-820 (previous significant resistance zone) - Ultimate Resistance: 900-920 (prior consolidation area) Technical Patterns: - Primary Pattern: Symmetrical Triangle - Secondary Pattern: Potential Cup and Handle formation within the larger triangle - Volume Pattern: Decreasing volume during consolidation with recent pickup suggesting breakout preparation - Price compression: Narrowing price range indicates imminent directional move Trade Setup: Entry Strategy: - Primary Entry: On breakout above 720-725 with volume confirmation - Secondary Entry: On pullback to 700-705 levels after successful breakout - Aggressive Entry: Current levels around 704-706 for risk-tolerant traders Exit Levels: - Target 1: 760-770 (measured move from triangle base) - Target 2: 800-820 (previous resistance zone) - Target 3: 860-880 (extended target based on base depth) - Ultimate Target: 920-950 (full triangle breakout target) Stop-Loss Strategy: - Conservative Stop-Loss: Below 680 (recent swing low) - Aggressive Stop-Loss: Below 695 (intraday support) - Trailing Stop: Move to breakeven once Target 1 is achieved Position Sizing: - Risk per trade: Maximum 2% of portfolio - Position size calculation: Based on stop-loss distance from entry - For entry at 705 with stop at 680: Risk of 25 points allows for appropriate position sizing - Recommended allocation: 3-5% of portfolio for medium-term holding Risk Management: - Maximum drawdown tolerance: 3-4% from entry point - Partial profit booking at each target level (25% at each target) - Trailing stop-loss implementation after achieving Target 1 - Time-based exit if no progress within 3-4 weeks Sectoral and Fundamental Backdrop: Sector Overview: - The speciality chemicals sector is showing resilience in the current market conditions - Increasing demand for sustainable and eco-friendly chemical solutions - The government push for domestic manufacturing under PLI schemes - Growing export opportunities in the speciality chemicals space Company Fundamentals: - Business Profile: Speciality chemicals manufacturer focusing on home, personal care, and fabric care segments - Revenue Growth: Consistent growth trajectory in recent quarters - Market Position: Strong presence in domestic market with expanding export footprint - Product Portfolio: Diversified range of speciality chemicals and ingredients Industry Tailwinds: - Increasing consumer spending on personal care products - Growing demand for sustainable and biodegradable chemical products - Import substitution opportunities in speciality chemicals - Rising per capita income is driving demand for quality personal care products Fundamental Catalysts: - New product launches and capacity expansions - Strategic partnerships and collaborations - Improving operational efficiency and margin expansion - Strong balance sheet supporting growth investments Risk Factors: Technical Risks: - Failure to sustain above 720 levels could lead to further consolidation - Breakdown below 680 could trigger deeper correction to 600-620 levels - Low liquidity may result in higher volatility during a breakout Fundamental Risks: - Raw material price inflation is impacting margins - Competitive pressure from larger players - Regulatory changes affecting product approvals - Currency fluctuation impact on export revenues My Take: NSE:ROSSARI presents an attractive risk-reward setup with a well-defined technical pattern and strong fundamental backdrop. The extended consolidation phase suggests substantial energy is building up for the next directional move. With proper risk management and disciplined execution, this setup offers multiple target levels for profit booking while maintaining manageable downside risk. Keep in the Watchlist. NO RECO. For Buy/Sell. 📌Thank you for exploring my idea! I hope you found it valuable. 🙏FOLLOW for more 👍BOOST if you found it useful. ✍️COMMENT below with your views. Meanwhile, check out my other stock ideas on the right side until this trade is activated. I would love your feedback. Disclaimer: "I am not a SEBI REGISTERED RESEARCH ANALYST AND INVESTMENT ADVISER." This analysis is intended solely for informational and educational purposes and should not be interpreted as financial advice. It is advisable to consult a qualified financial advisor or conduct thorough research before making investment decisions.
NSE:ROSSARILong
by Karanshah137
10
Specialty Chemicals Sees Sharp Rise on Refrigerant Price Hike◉ Key Takeaways ● The phasing down of HFCs in the U.S. is driving significant changes in the refrigerant market. ● Indian specialty chemicals companies, particularly those involved in refrigerant production, are poised to benefit from this market shift. ● The demand-supply imbalance in the refrigerant gas segment is expected to persist, creating favourable conditions for industry growth. ◉ Introduction On January 9, 2025, the Indian specialty chemicals sector witnessed a significant surge, driven by a sharp increase in refrigerant gas prices. This surge was primarily attributed to the phasing down of hydrofluorocarbons (HFCs) in the United States, as mandated by the U.S. Environmental Protection Agency (EPA). ◉ Market Dynamics ● Phasing down HFCs: The EPA aims to reduce hydrofluorocarbon (HFC) emissions by 85% over the next 15 years. This will impact the production and pricing of refrigerants. ● Refrigerant price increases: As HFC production declines, prices for existing refrigerants like R-410A and R-22 may rise. This could lead to higher costs for consumers and businesses. ● New refrigerant alternatives: The industry is shifting towards alternative refrigerants with lower global warming potential (GWP), such as R-32, R-454B, and R-1234yf. These alternatives may become more widely adopted and affordable. ◉ Impact on Indian Companies The surge in refrigerant gas prices significantly benefited leading Indian players: ● SRF NSE:SRF and Navin Fluorine NSE:NAVINFLUOR : These companies were prominent beneficiaries, witnessing a remarkable 14% increase in their stock prices. ● Financial Gains: Analysts estimate that every $1/kg increase in R32 prices could boost SRF's EBITDA by ₹260 crore and Navin Fluorine's by ₹77 crore. ● Capacity Expansion: With SRF's production capacity for R32 at approximately 29,000 to 30,000 tons and plans for Navin Fluorine to double its capacity from 4,500 tons to 9,000 tons by February 2025, both companies are well-positioned to capitalize on this market shift. ◉ Wider Market Impact The price hike triggered a broader rally in the specialty chemicals sector, with companies like Balaji Amines NSE:BALAMINES and Alkyl Amines NSE:ALKYLAMINE also witnessing stock price increases. ◉ Future Outlook As the U.S. transitions to more environmentally friendly refrigerants, the dynamics of supply and pricing for these alternatives are likely to continue evolving. This evolving landscape presents significant opportunities for Indian specialty chemicals companies that are well-positioned to capitalize on the growing demand for these new-generation refrigerants.
NSE:SRFLong
by GoodluckCapital
Aarti Industries: Elliott Wave Analysis – Progression ...Aarti Industries: Elliott Wave Analysis – Progression of Intermediate Wave 4 Aarti Industries, a key player in the specialty chemicals sector, is currently progressing through Intermediate Degree Wave 4 in its broader Elliott Wave structure. This analysis outlines the key phases of Aarti Industries' price action, including the formation of its primary and intermediate waves, and provides insights into the current corrective phase. Aarti Industries is currently in the process of forming Intermediate Degree Wave 4, with a triangle pattern likely unfolding. The stock has completed the initial corrective waves (A, B, and C) and is now expected to progress through Wave D and Wave E before completing the pattern. The targets for the remaining waves are as follows: Wave D is expected to target Rs. 685-700. Wave E may bring the stock price down to the Rs. 500-520 range. It’s important to note that this analysis is based on the principles of Elliott Wave theory and is subject to change as market conditions evolve. This report is for informational purposes only and does not constitute a buy or sell recommendation.
NSE:AARTIIND
by imkhushal
3
Jubilant Ingrevia for 60%+ gainsDate: 3 Oct’24 Stock: Jublingrea Timeframe: Daily chart Jubilant Ingrevia seems to be in Wave III of 3 which is heading towards 1300+ (60%+ from current price of 810) as seen in the chart. Wave III could end around 940 and Wave IV could correct to 750 levels (returns would be even higher if entered at the end of Wave IV of 3). High volume and strong RSI support this stance. If the industry tailwinds remain, it won’t surprise me if the target is done in a year’s time. This is not a trade recommendation. Please do your own analysis. Jubilant Ingrevia 3 ke Wave III mein dikh raha hai jo 1300+ (800 ki vartamaan keemat se 60%+) kee taraf badh raha hai jaisa ki chart mein dikh raha hai. Wave III 940 ke aas-paas samaapt ho sakta hai aur Wave IV 750 ke star tak neeche aa sakta hai (yadi 3 ke Wave IV ke ant mein entry ki jaye to return aur bhee adhik hoga). Adhik volume aur majaboot RSI is trend ka samarthan karate hain. Yadi sector mein teji kee sthiti banee rahee, to yah koee aascharya kee baat nahin hogee yadi lakshya ek varsh ke bheetar poora ho jae. Yeh koi invest karne ki hitaayad nahin hai. Kripya apana analysis khud karein.
NSE:JUBLINGREALong
by DhandhaPaani
2
Symmetrical Triangle Pattern Breakout seen in Rossari BiotechHello Everyone, i have brought a stock which has given breakout of symmetrical triangle pattern and price is sustaining above the breakout price, stock name is Rossari Biotech Ltd, and it was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. Their 3 main product categories are:- - Home, personal care, and performance chemicals - Textile specialty chemical - Animal health and nutrition The company has two R&D facilities , one at Silvassa manufacturing facility and a research lab at IIT Bombay. We know chemical sector is not performing well from long back, but prices are suggesting in many chemical stocks that, we can see rally very soon. Well best time to enter in any sector or stock is only when there is fear in sector or market. So this can be right time to enter and accumulate as much as possible in down levels, we might never gonna to see these prices again. Stock is trading almost 50% discount from all time all time highs. If someone is thinking to take and hold for long term, then i think right choice dude. Company Overview Rossari Biotech is a Specialty-Chemicals manufacturer offering solutions for Home, Personal Care and Performance chemicals (HPPC), Textile specialty chemicals (TSC) and Animal Health and Nutrition (AHN). It offers a total of 4220+ products catering to an array of applications across FMCG, Home care, Industrial Cleaning, Personal Care, Textile, Performance Chemicals, Animal Health and Nutrition and Pet Care businesses. Market Cap ₹ 4,467 Cr. Current Price ₹ 809 High / Low ₹ 904 / 657 Stock P/E 34.2 Book Value ₹ 190 Dividend Yield 0.07 % ROCE 18.3 % ROE 13.3 % Face Value ₹ 2.00 Industry PE 38.6 Debt ₹ 119 Cr. EPS ₹ 23.7 Promoter holding 68.3 % Intrinsic Value ₹ 590 Pledged percentage 0.00 % EVEBITDA 17.7 Change in Prom Hold -0.01 % Profit Var 5Yrs 23.3 % Sales growth 5Years 28.8 % Return over 5years % Debt to equity 0.11 Net profit ₹ 131 Cr. ROE 5Yr 16.0 % Profit growth 22.1 % Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
NSE:ROSSARILong
by TraderRahulPal
AETHER is forming triangle patternNSE:AETHER small cap scrip is forming triangle pattern. Revenue and income is consistently growing. Dept to ratio of 0.38 might be a concern, but its actually reduced from 0.61 in 2018, which is a good sign. But PE ratio is high compared to its peers and sector PE. Its good enough to enter in 840 to 920 range, and enter more on breakout. Key note : Always follow proper risk management to avoid losing capital from false breakouts as this is common. Caution : This is a knowledge sharing analysis, not a call.
NSE:AETHER
by samplespaz
Chemcon Speciality Chemicals | CHART#15CSCL, is a Vadodara, Gujarat based company incorporated in 1988, involved in manufacture of Pharmaceutical intermediates and Oilfield Chemicals. Chemcon specialty chemicals limited is the only manufacturer of HMDS (Hexamethyldisilazane / Hexamethyldisilane) in India & 3rd largest manufacturer of HMDS Worldwide. Chemcon has share of >10% in global market. *Stock Analysis* -- CSCL has been on consolidation since its IPO on October 2020. Now it has made second attempt to break primary resistance at 470 levels. -- Good Volume confirmation -- Once it touch take support at 470 levels the next target will be 510 and then to 625 levels. -- Moving average(10, 50) has good divergence. *Important Levels to Watch* -- Entry @ 470 -- Target @ 625 -- SL @ 468 and after breakout put trailing SL Note : India's specialty chemicals market to grow to $40 billion by 2025: McKinsey Good Luck Investors❗ - GokulHari
NSE:CHEMCONLong
by GokulHari